A First in Human Study of AX-202 in Healthy Subjects and Patients With Psoriasis.

NCT05965089 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Mild to Moderate Psoriasis

Interventions

BIOLOGICAL: Placebo
BIOLOGICAL: AX-202

Sponsor

Arxx Therapeutics